Reading this on a mobile device? Try our optimized mobile version here:

January 9, 2013
Sign upForwardArchiveAdvertise
News for nuclear medicine and molecular imaging professionals
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items below are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at

  Top Story 
  • GE seeks U.S., EU approval of imaging agent 18F-flutemetamol
    GE Healthcare has submitted a new drug application to the FDA and a marketing authorization application to the European Medicines Agency for its PET imaging agent 18F-flutemetamol. Both applications seek approval for the use of the imaging agent in visualizing beta amyloid levels in the brains of adults being assessed for Alzheimer's disease. (1/8) LinkedInFacebookTwitterEmail this Story
The MEDRAD™ Intego™ is making personalized PET practical.
Clinicians are able to set weight-based dosing formulas to determine and administer an accurate, personalized dose for each unique patient. Precise delivery and dose-on-demand capabilities enable lower patient dosing, leading to better patient care. To learn more, click here.
  Clinical News & Research 
  • Study: PET imaging with FAC may improve treatment of liposarcoma
    PET imaging with a tracer called FAC allowed for the detection of nucleoside salvage activity in liposarcoma tumor cells, according to a study published in the journal Cancer Discovery. The study also discovered liposarcoma cells with high nucleoside salvage activity are susceptible to the standard chemotherapy drug gemcitabine. The findings indicate the PET imaging strategy may improve identification of patients who would likely respond to gemcitabine treatment. Oncology Nurse Advisor online (1/8) LinkedInFacebookTwitterEmail this Story
  Industry Report 
  • Study finds imaging use decline in inpatient setting
    Researchers who reviewed Medicare Part B databases for 2000 to 2010 found that use of inpatient noninvasive diagnostic imaging declined from 32% to 25% for that time period. Use of nuclear medicine in the inpatient setting also decreased by 43%, according to the study, which was presented at a radiology meeting. The study did not include inpatient PET or bone densitometry because of the low utilization of the tests, a researcher said. (free registration) (1/8) LinkedInFacebookTwitterEmail this Story
  News from the Field 
  International Developments 
  • India plans tighter regulation of drug studies
    The Indian government plans to change laws governing drug trials to make violations by multinational corporations punishable and to improve compensation. Rules governing clinical studies under the Drugs and Cosmetics Act could be released this month. Trial investigators and sponsors would be required to address the medical management of subjects in cases of serious adverse events including death. The Economic Times (India)/Press Trust of India (1/4) LinkedInFacebookTwitterEmail this Story
  Health Policy 
  • Health care spending may be poised to accelerate, report finds
    Data from a CMS report showed U.S. spending on health care grew by 3.9% in 2011, marking the third year in a row of relatively small increases in spending. However, the report suggests spending growth may pick up in the coming years as the economy rebounds. The report appears in the journal Health Affairs. Reuters (1/7) LinkedInFacebookTwitterEmail this Story
  Advancing Health Care 
  From SNMMI 
  • SNMMI joins Choosing Wisely
    What tests and procedures should patients and physicians be talking about in nuclear medicine and molecular imaging? Find out Feb. 21 when SNMMI announces its "Five Things Physicians and Patients Should Question" as part of the ABIM Foundation's Choosing Wisely campaign. LinkedInFacebookTwitterEmail this Story
SNMMI  |  News  |  Meetings  |  Education  |  Publications  |  Membership

SNMMI on Facebook  |  SNMMI on LinkedIn  |  SNMMI on Twitter  |  SNMMI on YouTube

  Editor's Note 
  • Which news could you use?
    Complete our SNMMI SmartBrief reader survey and let us know. All responses are confidential, and you will help improve this publication. LinkedInFacebookTwitterEmail this Story
If you want to test your memory, try to recall what you were worrying about one year ago today."
--E. Joseph Cossman,
American entrepreneur and inventor

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

Account Director:   Meryl Harold   (202) 407-7828
 Recent SNMMI SmartBrief Issues:   Lead Editor:   Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.®  Legal Information